Serum metabolomic profiles associated with postmenopausal hormone use
Sign Up to like & getrecommendations! Published in 2018 at "Metabolomics"
DOI: 10.1007/s11306-018-1393-1
Abstract: IntroductionPostmenopausal hormone use is linked to several health outcomes and the risk associated with some may differ depending on whether estrogen is used alone or in combination with progestin.ObjectiveMetabolomic analyses of postmenopausal hormone use and… read more here.
Keywords: hormone; postmenopausal hormone; estrogen; estrogen plus ... See more keywords
Risk of Alzheimer's disease among users of postmenopausal hormone therapy: A nationwide case-control study.
Sign Up to like & getrecommendations! Published in 2017 at "Maturitas"
DOI: 10.1016/j.maturitas.2017.01.002
Abstract: OBJECTIVE To examine the association between postmenopausal hormone therapy (HT) and Alzheimer's disease (AD). METHODS Medicine and Alzheimer's disease (MEDALZ) is a nested case-control study of the entire Finnish population with clinically verified AD from… read more here.
Keywords: risk; alzheimer disease; postmenopausal hormone; study ... See more keywords
New evidence for cardiac benefit of postmenopausal hormone therapy
Sign Up to like & getrecommendations! Published in 2017 at "Climacteric"
DOI: 10.1080/13697137.2016.1262839
Abstract: Abstract Coronary artery disease (CAD) is still the most common killer of western women. Coronary arteries, expressing estrogen receptors, are a target for estrogen action. Prior to the Women’s Health Initiative (WHI) study, postmenopausal hormone… read more here.
Keywords: postmenopausal; hormone therapy; postmenopausal hormone; cad ... See more keywords
Postmenopausal hormone treatment alters neural pathways but does not improve verbal cognitive function
Sign Up to like & getrecommendations! Published in 2018 at "Menopause"
DOI: 10.1097/gme.0000000000001157
Abstract: Objective: Cognitive outcomes in trials of postmenopausal hormone treatment have been inconsistent. Differing outcomes may be attributed to hormone formulation, treatment duration and timing, and differential cognitive domain effects. We previously demonstrated treatment benefits on… read more here.
Keywords: treatment; postmenopausal hormone; cognitive function; function ... See more keywords
Oral postmenopausal hormone therapy and genetic risk on venous thromboembolism: gene-hormone interaction results from a large prospective cohort study
Sign Up to like & getrecommendations! Published in 2022 at "Menopause"
DOI: 10.1097/gme.0000000000001924
Abstract: Abstract Objective: Oral postmenopausal hormone therapy (HT) has been shown to be associated with venous thromboembolism (VTE), but whether this association is modified by VTE-associated genetic susceptibility is unknown. We examined interactions between oral HT… read more here.
Keywords: grs; vte; oral postmenopausal; risk ... See more keywords
Postmenopausal hormone therapy and Alzheimer disease
Sign Up to like & getrecommendations! Published in 2017 at "Neurology"
DOI: 10.1212/wnl.0000000000003696
Abstract: Objective: To explore the association between postmenopausal hormone therapy (HT) and Alzheimer disease (AD). Methods: Twenty-year follow-up data from the Kuopio Osteoporosis Risk Factor and Prevention study cohort were used. Self-administered questionnaires were sent to… read more here.
Keywords: alzheimer disease; therapy alzheimer; postmenopausal hormone; postmenopausal ... See more keywords